Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Metal Lewis Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109336811B introduces a bulky borane-catalyzed route for quinoline-4-carboxylates, eliminating heavy metals and ensuring high-purity pharmaceutical intermediates.
Patent CN114478290A reveals a metal halide catalyzed route for oseltamivir intermediates, offering superior purity and yield without column chromatography for reliable supply chains.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.
Solve 1,2,4-triazole synthesis challenges with iron-catalyzed method. Eliminate anhydrous conditions, reduce costs, and ensure scalable production for drug development.